Keywords: USA, FDA, PhRMA, BIO, PDUFA reauthroization, User fees

US pharma and FDA near agreement on PDUFA reauthorization, with 6% hike in user fees

Article | 05 September 2011

After many months of negotiations with the Food and Drug Administration, the USA’s pharmaceutical industry is close to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in